Multimorbidity in chronic disease: impact on health care resources and costs

SM McPhail - Risk management and healthcare policy, 2016 - Taylor & Francis
Effective and resource-efficient long-term management of multimorbidity is one of the
greatest health-related challenges facing patients, health professionals, and society more …

[HTML][HTML] Cost-effectiveness analysis alongside clinical trials II—an ISPOR Good Research Practices Task Force report

SD Ramsey, RJ Willke, H Glick, SD Reed… - Value in health, 2015 - Elsevier
Clinical trials evaluating medicines, medical devices, and procedures now commonly
assess the economic value of these interventions. The growing number of prospective …
Background Lack of standardization of outcome measures limits the usefulness of clinical
trial evidence to inform health care decisions. This can be addressed by agreeing on a …

Randomized controlled trial of rituximab and cost‐effectiveness analysis in treating fatigue and oral dryness in primary Sjögren's syndrome

SJ Bowman, CC Everett, JL O'Dwyer… - Arthritis & …, 2017 - Wiley Online Library
Objective To investigate whether rituximab, an anti–B cell therapy, improves symptoms of
fatigue and oral dryness in patients with primary Sjögren's syndrome (SS). Methods We …

Consolidated health economic evaluation reporting standards (CHEERS) statement

D Husereau, M Drummond, S Petrou, C Carswell… - Bmj, 2013 - bmj.com
Economic evaluations of health interventions pose a particular challenge for reporting.
There is also a need to consolidate and update existing guidelines and promote their use in …

Conceptualizing a model: a report of the ISPOR-SMDM modeling good research practices task force–2

M Roberts, LB Russell, AD Paltiel… - Medical Decision …, 2012 - journals.sagepub.com
The appropriate development of a model begins with understanding the problem that is
being represented. The aim of this article is to provide a series of consensus-based best …